U.S. tissue bank strikes deal for cell removal technology

06/18/2013 | Bloomberg

Community Tissue Services of Dayton, Ohio, will use U.K.-based Tissue Regenix's cell-removal technology to produce decellularized skin, which either company may then distribute in the U.S. The tissue will be used for wound care and burn products, among other uses. The technology allows Tissue Regenix to remove cells from animal tissue, creating a matrix for the patient's own cells to grow without rejecting the tissue.

View Full Article in:

Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX